Executive Board Changes at Merck


  • Kai Beckmann to assume responsibility for the Performance Materials business sector

  • Walter Galinat takes over responsibility for the Darmstadt site, Procurement as well as Environment and Quality

Darmstadt, Germany, August 03, 2017
The Personnel Committee of E. Merck KG has decided on changes in the responsibilities of the Executive Board of Merck KGaA, Darmstadt, effective September 1, 2017.

Walter Galinat (61) will hand over responsibility for the Performance Materials business of Merck to his Executive Board colleague Kai Beckmann (51). In return, Galinat will take on Executive Board responsibility for the Darmstadt site, Procurement as well as Environmental Protection, Quality and Safety.

With these changes to the Executive Board, we are underscoring personnel continuity within the Board while setting the course for the future of Performance Materials,” said Johannes Baillou, Chairman of the Board of Partners of E. Merck KG and its Personnel Committee. In addition, in his new role Galinat will further advance both the construction and organizational preparations for the 350th anniversary celebration of Merck in 2018.

Over the past decade, Walter Galinat has led Performance Materials from one success to the next. We are very grateful to him for this. At the same time, we are pleased to continue building on his vast wealth of experience,” said Baillou. “As an experienced member of Merck’s Executive Board, Kai Beckmann has extensive business, technological and international expertise, among other things from the very important Asian market. For him and for Merck, the aim now is to build on the long and successful development of Performance Materials, leading it into the future in times of increasingly dynamic developments in the liquid crystals market.”

Belén Garijo (57), CEO Healthcare, will additionally take over Executive Board responsibility for Group Human Resources from Kai Beckmann. Udit Batra (46), CEO Life Science, will be responsible for Business Technology, in other words the IT landscape of the Merck Group. In addition to his role as Chief Financial Officer, Marcus Kuhnert (48) will be responsible for Merck Business Services, a newly formed unit.

CVs of the Members of the Executive Board can be found here.

Merck KGaA
Frankfurter Str. 250
64293 Darmstadt

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

« back